Ingevity reports Q3 sales of $155 million and free cash flow of $118 million

Reuters
Nov 06
Ingevity reports Q3 sales of $155 million and free cash flow of $118 million

Ingevity Corporation reported third quarter 2025 net sales of $155.0 million for its Performance Materials segment, a 2.6% increase compared to $151.1 million in the same period of 2024. Segment EBITDA for Performance Materials was $79.9 million, down 0.9% from $80.6 million in the prior year, with an EBITDA margin of 51.5%, representing a decline of 180 basis points. The company generated $118.0 million in free cash flow during the quarter and repurchased $25.0 million in shares. Ingevity also announced the sale of its North Charleston crude tall oil refinery and the majority of the Industrial Specialties product line for $110.0 million, which are now reported as discontinued operations beginning in the third quarter. Net leverage improved to 2.7x. Ruth Castillo was named senior vice president and president for Performance Materials.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ingevity Corporation published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10